TABLE 2

125I-α-Bungarotoxin binding (fentomoles per milligram of tissue)

Quantitative distribution of 125I-α-bungarotoxin binding in the brain regions of non-transgenic controls (non-tg) and APPswe transgenic mice (APPswe). Data are expressed as mean ± S.E.M.


Brain Region

Saline

Memantine

Galantamine

Nicotine
Non-tg (n = 9)
APPswe (n = 5)
Non-tg (n = 10)
APPswe (n = 5)
Non-tg (n = 7)
APPswe (n = 5)
Non-tg (n = 6)
APPswe (n = 5)
Cortex 6.16 ± 0.58 8.37 ± 0.79* 7.49 ± 0.62 8.88 ± 1.22 6.98 ± 0.62 7.98 ± 0.60 7.89 ± 0.97 10.59 ± 0.56#
    Frontal cortex 5.00 ± 0.30 6.34 ± 0.87 5.83 ± 0.58 6.51 ± 0.68 6.25 ± 0.61 6.39 ± 1.00 5.79 ± 0.51 7.69 ± 0.86
    Retrosp gr. cortex 3.14 ± 0.33 4.59 ± 0.79 4.53 ± 0.74 5.09 ± 0.95 4.37 ± 0.53# 4.57 ± 0.78 4.71 ± 0.74 5.60 ± 0.41
    Temp/parietal cortex 6.85 ± 0.64 9.90 ± 0.55* 8.28 ± 0.98 10.06 ± 1.42 7.97 ± 0.70 8.94 ± 0.69 9.54 ± 1.51 12.60 ± 0.77#
Hippocampus 10.82 ± 0.35 12.77 ± 0.93 11.78 ± 0.92 14.12 ± 1.18 10.43 ± 1.27 11.87 ± 1.05 12.42 ± 1.24 15.21 ± 0.88
    CA1 11.85 ± 1.02 15.82 ± 1.57 14.08 ± 1.35 20.44 ± 2.10 10.73 ± 2.14 16.14 ± 2.28 14.64 ± 1.91 20.33 ± 2.88
    CA2 8.38 ± 0.45 10.15 ± 0.89 9.38 ± 20.97 11.41 ± 1.60 8.73 ± 0.83 9.92 ± 1.13 11.20 ± 1.12# 12.75 ± 1.26
    CA3 14.40 ± 0.36 16.73 ± 1.18 14.67 ± 1.20 18.56 ± 1.95 13.73 ± 1.81 16.52 ± 2.29 15.89 ± 1.82 20.29 ± 1.07#
Caudate nucleus 2.70 ± 0.20 2.92 ± 0.31 2.47 ± 0.26 3.19 ± 0.31 3.46 ± 20.54 2.83 ± 0.20 3.85 ± 0.55 3.76 ± 0.59
Thalamus
4.59 ± 0.37
4.56 ± 0.26
4.24 ± 0.51
4.81 ± 0.34
4.56 ± 0.55
4.71 ± 0.48
5.39 ± 0.55
5.53 ± 0.60
  • * P < 0.05 vs. nontransgenic (Non-tg) mice in the same treatment group, and # P < 0.05 compared with saline-treated non-tg or APPswe, respectively (Kruskall-Wallis followed by Mann-Whitney post hoc test).